Eyes of African-Americans who have glaucoma tend to have much higher oxygen levels than those of Caucasians with the disease, according to a news release by Washington University School of Medicine in St. Louis.
Uncategorized
A German researcher is proposing to use energy from sugar and oxygen in the blood to power implantable devices, according to a report by News Medical.
As Florida's new pill mill legislation cuts off dealers and addicts from prescription painkillers, drug treatment centers in the state are bracing for a wave of new patients, according to a report by the Palm Beach Post.
In a meeting with FDA officials, representatives of the medical device industry warned the agency not to become overly dependent on user fees to fund its budget, according to a report by Mass Device.
Six University of California facilities received nine grants totaling $3.4 million for projects designed to understanding and resolve common obstacles to health quality, according to a UCLA news release. Read the full report in Becker’s Hospital Review on the UC…
Advertisement
A former physician from Knoxville, Tenn., has been sentenced to one year in prison after pleading guilty to healthcare fraud and failure to file tax returns, according to a Knoxville News Sentinel report. Allen R. Foster, MD, used a fast-track…
6 Best Specialties for Surgery Centers Specialty choice can make or break an ASC, depending on reimbursement rates, supply costs, case volume and availability of market share. Click to continue » 12 Major Issues Facing the Surgery Center Industry The…
Researchers found individuals who drink coffee or hot tea are less likely to be MRSA nasal carriers than those who do not drink coffee or hot tea, according to a study published in the Annals of Family Medicine.
Researchers are testing a wireless power source that would eliminate electric power attachments for implanted medical devices, according to a news release by the University of Washington.
The FDA has approved Archimedes Pharma's Lazanda nasal spray for the management of breakthrough pain in adult cancer patients, according to a report by the FDA.